No association between BCR-ABL1 fusion genes and clinical features of acute lymphoblastic leukaemia in Ghanaian patients

INTRODUCTION: The BCR-ABL1 fusion gene has been associated with poor prognosis in acute lymphoblastic leukaemia (ALL). This study was designed to determine the presence, frequency and associated laboratory and clinical features of the BCR-ABL1 gene in Ghanaian patients diagnosed with ALL.Methods: th...

Full description

Bibliographic Details
Main Authors: Victor Obeng Ofori, Amma Benneh-Akwasi Kuma, Susan Crocker, Edeghonghon Olayemi
Format: Article
Language:English
Published: PAMJ 2020-10-01
Series:PAMJ Clinical Medicine
Subjects:
Online Access: https://www.clinical-medicine.panafrican-med-journal.com/content/article/4/57/pdf/57.pdf
id doaj-3decefb2830440069a91c7f4a18fcd8b
record_format Article
spelling doaj-3decefb2830440069a91c7f4a18fcd8b2020-12-23T05:30:05ZengPAMJPAMJ Clinical Medicine 2707-27972707-27972020-10-0145710.11604/pamj-cm.2020.4.57.2282922829No association between BCR-ABL1 fusion genes and clinical features of acute lymphoblastic leukaemia in Ghanaian patientsVictor Obeng Ofori0Amma Benneh-Akwasi Kuma1Susan Crocker2Edeghonghon Olayemi3 Haematology Unit, Komfo Anokye Teaching Hospital, Kumasi, Ghana Department of Haematology, University of Ghana Medical School, Accra, Ghana Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre (Kingston General Hospital Site)/Queen's University, Kingston, Ontario, Canada Department of Haematology, University of Ghana Medical School, Accra, Ghana INTRODUCTION: The BCR-ABL1 fusion gene has been associated with poor prognosis in acute lymphoblastic leukaemia (ALL). This study was designed to determine the presence, frequency and associated laboratory and clinical features of the BCR-ABL1 gene in Ghanaian patients diagnosed with ALL.Methods: this was a cross-sectional study using archival methanol-fixed bone marrow aspirate slides of morphologically diagnosed ALL patients. Presence of the BCR-ABL1fusion gene was determined by fluorescent in situ hybridization. Clinical features and haematological parameters were extracted from the patients´ medical records.Results: seventeen patients were studied, 13 (76.5%) males and 4 (23.5%) females. Median age was 24 years (range 15 to 67 years). A frequency of 29.4% was obtained for the BCR-ABL1 fusion gene. There was no significant association between presence of BCR-ABL1 and selected clinical features (lymphadenopathy, splenomegaly and hepatomegaly). All patients had moderate to severe anaemia with median haemoglobin concentration of 7.6 g/dL (range 3.7 to 8.7 g/dL). Median haemoglobin concentration for BCR-ABL1 positive patients was higher than that for negative patients (7.6 vs. 7.4 g/dL, p = 0.506); who also had higher median white blood cell counts (24.76 vs. 13.02 X 109/L), but lower median platelet counts (58.0 vs. 64.5 X 109/L, p = 0.721) and bone marrow blast percentages (78.5 vs. 98.0%, p = 0.851) compared to negative patients.Conclusion: BCR-ABL1 fusion gene was detected in nearly one third of adult ALL patients in this study, with no significant association with common haematological parameters and clinical features of the disease. https://www.clinical-medicine.panafrican-med-journal.com/content/article/4/57/pdf/57.pdf bcr-abl1 fusion geneacute lymphoblastic leukaemiaclinical and laboratory features
collection DOAJ
language English
format Article
sources DOAJ
author Victor Obeng Ofori
Amma Benneh-Akwasi Kuma
Susan Crocker
Edeghonghon Olayemi
spellingShingle Victor Obeng Ofori
Amma Benneh-Akwasi Kuma
Susan Crocker
Edeghonghon Olayemi
No association between BCR-ABL1 fusion genes and clinical features of acute lymphoblastic leukaemia in Ghanaian patients
PAMJ Clinical Medicine
bcr-abl1 fusion gene
acute lymphoblastic leukaemia
clinical and laboratory features
author_facet Victor Obeng Ofori
Amma Benneh-Akwasi Kuma
Susan Crocker
Edeghonghon Olayemi
author_sort Victor Obeng Ofori
title No association between BCR-ABL1 fusion genes and clinical features of acute lymphoblastic leukaemia in Ghanaian patients
title_short No association between BCR-ABL1 fusion genes and clinical features of acute lymphoblastic leukaemia in Ghanaian patients
title_full No association between BCR-ABL1 fusion genes and clinical features of acute lymphoblastic leukaemia in Ghanaian patients
title_fullStr No association between BCR-ABL1 fusion genes and clinical features of acute lymphoblastic leukaemia in Ghanaian patients
title_full_unstemmed No association between BCR-ABL1 fusion genes and clinical features of acute lymphoblastic leukaemia in Ghanaian patients
title_sort no association between bcr-abl1 fusion genes and clinical features of acute lymphoblastic leukaemia in ghanaian patients
publisher PAMJ
series PAMJ Clinical Medicine
issn 2707-2797
2707-2797
publishDate 2020-10-01
description INTRODUCTION: The BCR-ABL1 fusion gene has been associated with poor prognosis in acute lymphoblastic leukaemia (ALL). This study was designed to determine the presence, frequency and associated laboratory and clinical features of the BCR-ABL1 gene in Ghanaian patients diagnosed with ALL.Methods: this was a cross-sectional study using archival methanol-fixed bone marrow aspirate slides of morphologically diagnosed ALL patients. Presence of the BCR-ABL1fusion gene was determined by fluorescent in situ hybridization. Clinical features and haematological parameters were extracted from the patients´ medical records.Results: seventeen patients were studied, 13 (76.5%) males and 4 (23.5%) females. Median age was 24 years (range 15 to 67 years). A frequency of 29.4% was obtained for the BCR-ABL1 fusion gene. There was no significant association between presence of BCR-ABL1 and selected clinical features (lymphadenopathy, splenomegaly and hepatomegaly). All patients had moderate to severe anaemia with median haemoglobin concentration of 7.6 g/dL (range 3.7 to 8.7 g/dL). Median haemoglobin concentration for BCR-ABL1 positive patients was higher than that for negative patients (7.6 vs. 7.4 g/dL, p = 0.506); who also had higher median white blood cell counts (24.76 vs. 13.02 X 109/L), but lower median platelet counts (58.0 vs. 64.5 X 109/L, p = 0.721) and bone marrow blast percentages (78.5 vs. 98.0%, p = 0.851) compared to negative patients.Conclusion: BCR-ABL1 fusion gene was detected in nearly one third of adult ALL patients in this study, with no significant association with common haematological parameters and clinical features of the disease.
topic bcr-abl1 fusion gene
acute lymphoblastic leukaemia
clinical and laboratory features
url https://www.clinical-medicine.panafrican-med-journal.com/content/article/4/57/pdf/57.pdf
work_keys_str_mv AT victorobengofori noassociationbetweenbcrabl1fusiongenesandclinicalfeaturesofacutelymphoblasticleukaemiainghanaianpatients
AT ammabennehakwasikuma noassociationbetweenbcrabl1fusiongenesandclinicalfeaturesofacutelymphoblasticleukaemiainghanaianpatients
AT susancrocker noassociationbetweenbcrabl1fusiongenesandclinicalfeaturesofacutelymphoblasticleukaemiainghanaianpatients
AT edeghonghonolayemi noassociationbetweenbcrabl1fusiongenesandclinicalfeaturesofacutelymphoblasticleukaemiainghanaianpatients
_version_ 1724373132031033344